Human iPS cell derived RPE strips for secure delivery of graft cells at a target place with minimal surgical invasion
Abstract Several clinical studies have been conducted into the practicality and safety of regenerative therapy using hESC/iPSC-retinal pigment epithelium (RPE) as a treatment for the diseases including age-related macular degeneration. These studies used either suspensions of RPE cells or an RPE cel...
Guardado en:
Autores principales: | Mitsuhiro Nishida, Yuji Tanaka, Yo Tanaka, Satoshi Amaya, Nobuyuki Tanaka, Hirofumi Uyama, Tomohiro Masuda, Akishi Onishi, Junki Sho, Satoshi Yokota, Masayo Takahashi, Michiko Mandai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0d0f6de5ad7845f5b720b0fcdc7f407c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Generation of Col2a1-EGFP iPS cells for monitoring chondrogenic differentiation.
por: Taku Saito, et al.
Publicado: (2013) -
CD82 is a marker to isolate β cell precursors from human iPS cells and plays a role for the maturation of β cells
por: Ami Watanabe, et al.
Publicado: (2021) -
Tumorigenicity studies of induced pluripotent stem cell (iPSC)-derived retinal pigment epithelium (RPE) for the treatment of age-related macular degeneration.
por: Hoshimi Kanemura, et al.
Publicado: (2014) -
Synergistic gene editing in human iPS cells via cell cycle and DNA repair modulation
por: Thomas L. Maurissen, et al.
Publicado: (2020) -
Impaired NEPHRIN localization in kidney organoids derived from nephrotic patient iPS cells
por: Tomoko Ohmori, et al.
Publicado: (2021)